Showing results (1691-1700 of 2,241) with videos related to

Sort By:
Pageof 225
Biochemical and Biophysical Research Communications|February 21, 2021
Inhibition of fibroblast IL-6 production by ACKR4 deletion alleviates cardiac remodeling after myocardial infarctionMin Zhang, Min Zhang, Ting Zhou, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2007
Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinomaXiao-Fang Liu, Fan-Min Kong, Zheng Xu, et al.
World Journal of Clinical Cases|May 23, 2022
Cervical aortic arch with aneurysm formation and an anomalous right subclavian artery and left vertebral artery: A case reportYao-Kun Wu, Qi Mao, Mao-Ting Zhou, et al.
Journal for Immunotherapy of Cancer|September 1, 2020
Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysisXinru Chen, Zhonghan Zhang, Xue Hou, et al.
Frontiers in Oncology|November 1, 2021
MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal CarcinomaXi-Zhao Li, Yi-Jun Tu, Ting Zhou, et al.
Molecular Therapy. Nucleic Acids|February 4, 2022
Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunityHusun Qian, Ting Zhou, Yixin Fu, et al.
Frontiers in Medicine|October 22, 2021
The Abnormal Imaging of SARS-CoV-2: A Predictive Measure of Disease SeverityShangwen Pan, Huaqing Shu, Yaxin Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2015
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR MutationNan Chen, Wenfeng Fang, Jianhua Zhan, et al.
Pageof 225